Evidence map›Paper›PMID 37061661›Full record

ArticleInternational journal of clinical pharmacy2023

Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT).

Angela E Schulthess-Lisibach, Giulia Gallucci, Valérie Benelli, Ramona Kälin, Sven Schulthess, Marco Cattaneo, Patrick E Beeler, Chantal Csajka, Monika Lutters

Open access · hybridAbstract read
In one paragraph

Article in International journal of clinical pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Angela E Schulthess-LisibachClinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.ORCID http://orcid.org/0000-0001-8697-492X
Giulia GallucciClinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Valérie BenelliClinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Ramona KälinClinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Sven SchulthessClinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Marco CattaneoDepartment of Clinical Research, University of Basel, Schanzenstrasse 55, Basel, Switzerland.
Patrick E BeelerDivision of Occupational and Environmental Medicine, Epidemiology, Biostatistics and Prevention Institute, University of Zurich & University Hospital Zurich, Zurich, Switzerland.
Chantal CsajkaCenter for Research and Innovation in Clinical Pharmaceutical Sciences, University Hospital and University of Lausanne, Rue du Bugnon 17, 1005, Lausanne, Switzerland. Chantal.Csajka@chuv.ch.
Monika LuttersClinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Kantonsspital Baden · CHUniversity of Geneva · CHUniversity of Basel · CHUniversity of Lucerne · CH

Funding

GSASA Research Project of National Interest 2017
6 · The paper itself

Abstract

backgroundEffective delirium prevention could benefit from automatic risk stratification of older inpatients using routinely collected clinical data.

aimPrimary aim was to develop and validate a delirium prediction model (DELIKT) suitable for implementation in hospitals. Secondary aim was to select an anticholinergic burden scale as a predictor.

methodWe used one cohort for model development and another for validation with electronically available data collected within the first 24 h of admission. Included were patients aged ≥ 65, hospitalised ≥ 48 h with no stay > 24 h in an intensive care unit. Predictors, such as administrative and laboratory variables or an anticholinergic burden scale, were selected using a combination of feature selection filter method and forward/backward selection. The final model was based on logistic regression and the DELIKT was derived from the β-coefficients. We report the following performance measures: area under the curve, sensitivity, specificity and odds ratio.

resultsBoth cohorts were similar and included over 10,000 patients each (mean age 77.6 ± 7.6 years) with 11% experiencing delirium. The model included nine variables: age, medical department, dementia, hemi-/paraplegia, catheterisation, potassium, creatinine, polypharmacy and the anticholinergic burden measured with the Clinician-rated Anticholinergic Scale (CrAS). The external validation yielded an AUC of 0.795. With a cut-off at 20 points in the DELIKT, we received a sensitivity of 79.7%, specificity of 62.3% and an odds ratio of 5.9 (95% CI 5.2, 6.7).

conclusionThe DELIKT is a potentially automatic tool with predictors from standard care including the CrAS to identify patients at high risk for delirium.

Indexed as

DeliriumAgedAged, 80 and overCholinergic AntagonistsHospitalizationHumansInpatientsIntensive Care UnitsCholinergic AntagonistsAdverse effectsAgedCholinergic antagonistsClinical decision rulesDelirium

Identifiers

PMID37061661
PMCPMC10600272
OpenAlexW4365813739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.